We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-22.15%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.71M
AUM Growth
-$2.21M
Cap. Flow
-$547K
Cap. Flow %
-20.18%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
–
Reduced
2
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TRAW icon
Traws Pharma
TRAW
+$452K
2
MMAC
MMA Capital Holdings, Inc. Common Stock
MMAC
+$94.9K

Sector Composition

Rank Sector Weight
1 Financials 80.36%
2 Healthcare 19.34%
3 Miscellaneous 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMAC
1
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$2.18M 80.36%
72,552
-3,100
-4% -$94.9K
TRAW icon
2
Traws Pharma
TRAW
$8.98M
$524K 19.34%
1,644
-525
-24% -$452K
ONTXW
3
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$8K 0.3%
390,624
– –

Similar funds

CCM
Cota Capital Management San Francisco, California $177K AUM 63.94% 1-Year Est. Return
HIP
Hatteras Investment Partners Raleigh, North Carolina $169K AUM 86.49% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
ADIM
Alpha DNA Investment Management Columbia, Maryland $8.98M AUM 26.05% 1-Year Est. Return

Tyndall Capital Partners's Q3 2019 Portfolio in Review

As of Q3 2019, Tyndall Capital Partners held 3 positions worth $2.71M, down 45% from $4.92M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tyndall Capital Partners withdrew a net $547K in Q3 2019, reducing 2 holdings. Its largest reduction was Traws Pharma, cutting an estimated $452K.

By sector, the portfolio is most concentrated in Financials at 80% of assets, up from 51% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Tyndall Capital Partners's biggest Q3 2019 reduction was Traws Pharma, cutting an estimated $452K.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $2.71M portfolio in Q3 2019.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q3 2019.
  • Tyndall Capital Partners's portfolio value fell 45% quarter-over-quarter to $2.71M.

Based on Tyndall Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.